agalsidase beta
SpainDrugs containing this active substance
-
It is used as enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease, a condition in which there is insufficient activity of the α-galactosidase enzyme and a fatty substance accumulates in the walls of the blood vessels of the organs.
Form: powder for concentrate for solution for infusion
Active substance Dosage agalsidase beta 5 mg Manufacturer: Sanofi B.V.
-
It is used as enzyme replacement therapy to treat Fabry disease, a condition in which the body cannot properly eliminate a fatty substance called globotriaosylceramide (GL-3).
Form: powder for concentrate for solution for infusion
Active substance Dosage agalsidase beta 5 mg Manufacturer: Sanofi B.V.